Evidence map›Paper›PMID 33253156›Full record

ArticlePLoS genetics2020

A context-dependent bifurcation in the Pointed transcriptional effector network contributes specificity and robustness to retinal cell fate acquisition.

Chudong Wu, Jean-François Boisclair Lachance, Michael Z Ludwig, Ilaria Rebay

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. ETS‑1/ETS‑2 transcription factors in CVD (Review).International journal of molecular medicine · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Chudong WuCommittee on Genetics, Genomics and Systems Biology, University of Chicago, Chicago, Illinois, United States of America.ORCID 0000-0002-4769-2935
Jean-François Boisclair LachanceDepartment of Human Genetics, McGill University, Montreal, Quebec, Canada.ORCID 0000-0002-9828-7809
Michael Z LudwigDepartment of Ecology and Evolution, University of Chicago, Chicago, Illinois, United States of America.
Ilaria RebayCommittee on Genetics, Genomics and Systems Biology, University of Chicago, Chicago, Illinois, United States of America.ORCID 0000-0002-2444-3864
University of Chicago · USMcGill University · CA

Funding

VIRAL ONCOLOGY CORE FACILITYP30CA014599 · NCI · UNIVERSITY OF CHICAGO · PI CHIEN-MIN KAO · 1985 to 2026
$122.1M
Function and Regulation of the ETS Transcriptional Repressor Tel-1/YANR01GM080372 · NIGMS · UNIVERSITY OF CHICAGO · PI REBAY, ILARIA · 2007 to 2022
$3.9M
A systems-level study of signaling networks and differentiationR01EY025957 · NEI · UNIVERSITY OF CHICAGO · PI CARTHEW, RICHARD W., DINNER, AARON · 2016 to 2018
$1.5M
NCI NIH HHS P30 CA014599NEI NIH HHS R01 EY025957NIGMS NIH HHS R01 GM080372
6 · The paper itself

Abstract

Spatiotemporally precise and robust cell fate transitions, which depend on specific signaling cues, are fundamental to the development of appropriately patterned tissues. The fidelity and precision with which photoreceptor fates are recruited in the Drosophila eye exemplifies these principles. The fly eye consists of a highly ordered array of ~750 ommatidia, each of which contains eight distinct photoreceptors, R1-R8, specified sequentially in a precise spatial pattern. Recruitment of R1-R7 fates requires reiterative receptor tyrosine kinase / mitogen activated protein kinase (MAPK) signaling mediated by the transcriptional effector Pointed (Pnt). However the overall signaling levels experienced by R2-R5 cells are distinct from those experienced by R1, R6 and R7. A relay mechanism between two Pnt isoforms initiated by MAPK activation directs the universal transcriptional response. Here we ask how the generic Pnt response is tailored to these two rounds of photoreceptor fate transitions. We find that during R2-R5 specification PntP2 is coexpressed with a closely related but previously uncharacterized isoform, PntP3. Using CRISPR/Cas9-generated isoform specific null alleles we show that under otherwise wild type conditions, R2-R5 fate specification is robust to loss of either PntP2 or PntP3, and that the two activate pntP1 redundantly; however under conditions of reduced MAPK activity, both are required. Mechanistically, our data suggest that intrinsic activity differences between PntP2 and PntP3, combined with positive and unexpected negative transcriptional auto- and cross-regulation, buffer first-round fates against conditions of compromised RTK signaling. In contrast, in a mechanism that may be adaptive to the stronger signaling environment used to specify R1, R6 and R7 fates, the Pnt network resets to a simpler topology in which PntP2 uniquely activates pntP1 and auto-activates its own transcription. We propose that differences in expression patterns, transcriptional activities and regulatory interactions between Pnt isoforms together facilitate context-appropriate cell fate specification in different signaling environments.

Indexed as

Gene Expression Regulation, DevelopmentalAllelesAnimalsCell DifferentiationDNA-Binding ProteinsDrosophila melanogasterDrosophila ProteinsGene Regulatory NetworksMAP Kinase Signaling SystemModels, AnimalNerve Tissue ProteinsPhotoreceptor Cells, InvertebrateProtein IsoformsProto-Oncogene ProteinsSpatio-Temporal AnalysisTranscription FactorsDNA-Binding ProteinsDrosophila ProteinsNerve Tissue Proteinspnt protein, DrosophilaProtein IsoformsProto-Oncogene ProteinsTranscription Factors

Identifiers

PMID33253156
PMCPMC7728396
OpenAlexW3106686816

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.